Literature DB >> 3476023

Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.

H P McDowell, P Shears, C A Hart, J Martin.   

Abstract

A cross sectional study was carried out in children receiving treatment for acute lymphoblastic leukaemia to determine the prevalence of trimethoprim resistant organisms in their gut flora and to compare this with a control population. There was a significantly higher prevalence of trimethoprim resistant bacteria in the study group (61%) compared with controls (14%). A longitudinal study showed that emergence of these organisms was intermittent during treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3476023      PMCID: PMC1778445          DOI: 10.1136/adc.62.6.573

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection.

Authors:  N J Pearson; K J Towner; A M McSherry; W R Cattell; F O'Grady
Journal:  Lancet       Date:  1979-12-08       Impact factor: 79.321

2.  Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistances from R483 to other replicons.

Authors:  P T Barth; N Datta; R W Hedges; N J Grinter
Journal:  J Bacteriol       Date:  1976-03       Impact factor: 3.490

3.  Nosocomial gentamicin- and multiply-resistant enterobacteria at one hospital. Factors associated with carriage.

Authors:  C A Hart
Journal:  J Hosp Infect       Date:  1982-06       Impact factor: 3.926

4.  Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia.

Authors:  I J Lewis; D Mainwaring; J Martin
Journal:  Arch Dis Child       Date:  1982-09       Impact factor: 3.791

5.  Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors:  R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.

Authors:  I D Starke; P Donnelly; D Catovsky; J Darrell; S A Johnson; J M Goldman; D A Galton
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

7.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

8.  Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.

Authors:  A M Goorin; B J Hershey; M J Levin; G R Siber; R D Gelber; K Flynn; M Lew; K Beckett; P Blanding; S E Sallan
Journal:  Pediatr Infect Dis       Date:  1985 May-Jun

9.  Co-trimoxazole for prevention of infection in acute leukaemia.

Authors:  A Enno; D Catovsky; J Darrell; J M Goldman; J Hows; D A Galton
Journal:  Lancet       Date:  1978-08-19       Impact factor: 79.321

10.  Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.

Authors:  B E Murray; E R Rensimer; H L DuPont
Journal:  N Engl J Med       Date:  1982-01-21       Impact factor: 91.245

View more
  1 in total

1.  Occurrence of multiple antibiotic resistance and R plasmids in Enterobacteriaceae isolated from children in the Sudan.

Authors:  P Shears; G Suliman; C A Hart
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.